We are live on ! Find out more
ATEX icon

Anterix

115 hedge funds and large institutions have $593M invested in Anterix in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 36 increasing their positions, 32 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 11

20% more capital invested

Capital invested by funds: $493M → $593M (+$100M)

17% more funds holding

Funds holding: 98115 (+17)

13% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 32

1.46% more ownership

Funds ownership: 79.23%80.7% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

70% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $4.17M

Holders
115
Holders Change
+17
Holders Change %
+17.35%
% of All Funds
1.66%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
29
Increased
36
Reduced
32
Closed
11
Calls
$1.24M
Puts
$4.17M
Net Calls
-$2.94M
Net Calls Change
-$4.31M

ATEX Hedge Fund Activity: Q2 2024 in Review

115 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Anterix (ATEX) for Q2 2024, worth a combined $593M — up 20% from $493M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ATEX positions and 11 closed out — a net gain of 18 holders — while 36 added to existing stakes and 32 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.2M. The largest seller was Morgan Stanley, cutting an estimated $7.19M.

  • 115 institutional investors held Anterix (ATEX) as of Q2 2024, up from 98 in Q1 2024.
  • Funds reported $593M of Anterix stock for Q2 2024, up 20% quarter-over-quarter.
  • 29 funds opened new Anterix positions in Q2 2024 and 11 closed out, a net change of +18 holders.
  • The largest Anterix buyer in Q2 2024 was Citadel Advisors, an estimated $3.2M added.
  • The largest Anterix seller in Q2 2024 was Morgan Stanley, an estimated $7.19M sold.

Based on aggregated 13F filings for Q2 2024.